USANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert A. Fuller Sells 675 Shares of Stock

by · The Cerbat Gem

USANA Health Sciences, Inc. (NYSE:USNA – Get Free Report) Director Gilbert A. Fuller sold 675 shares of the stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $37.71, for a total value of $25,454.25. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Gilbert A. Fuller also recently made the following trade(s):

  • On Wednesday, August 7th, Gilbert A. Fuller sold 674 shares of USANA Health Sciences stock. The shares were sold at an average price of $39.69, for a total transaction of $26,751.06.

USANA Health Sciences Trading Up 2.9 %

USANA Health Sciences stock opened at $39.03 on Wednesday. The firm has a market capitalization of $743.43 million, a price-to-earnings ratio of 13.79, a price-to-earnings-growth ratio of 1.29 and a beta of 0.89. The firm’s fifty day moving average price is $37.53 and its two-hundred day moving average price is $42.08. USANA Health Sciences, Inc. has a 1-year low of $34.15 and a 1-year high of $54.81.

USANA Health Sciences (NYSE:USNA – Get Free Report) last announced its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.07. The business had revenue of $200.22 million for the quarter, compared to analysts’ expectations of $208.45 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. During the same quarter last year, the firm earned $0.59 EPS. On average, research analysts forecast that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Wall Street Analysts Forecast Growth

USNA has been the topic of several research reports. StockNews.com lowered shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 24th. DA Davidson cut their price target on USANA Health Sciences from $38.00 to $35.00 and set a “neutral” rating on the stock in a report on Wednesday, October 23rd.

Get Our Latest Analysis on USNA

Institutional Investors Weigh In On USANA Health Sciences

Several institutional investors have recently bought and sold shares of the stock. BNP Paribas Financial Markets boosted its holdings in USANA Health Sciences by 18.1% during the 1st quarter. BNP Paribas Financial Markets now owns 38,820 shares of the company’s stock worth $1,883,000 after acquiring an additional 5,952 shares during the last quarter. State Board of Administration of Florida Retirement System increased its stake in USANA Health Sciences by 22.7% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 8,430 shares of the company’s stock valued at $409,000 after buying an additional 1,560 shares during the last quarter. BOKF NA lifted its position in shares of USANA Health Sciences by 274.5% during the 1st quarter. BOKF NA now owns 2,771 shares of the company’s stock worth $133,000 after buying an additional 2,031 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its stake in shares of USANA Health Sciences by 9.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company’s stock worth $284,000 after buying an additional 494 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. grew its holdings in shares of USANA Health Sciences by 2.6% in the first quarter. Jacobs Levy Equity Management Inc. now owns 111,492 shares of the company’s stock valued at $5,407,000 after acquiring an additional 2,820 shares in the last quarter. Institutional investors own 54.25% of the company’s stock.

About USANA Health Sciences

(Get Free Report)

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.

Featured Stories